GS MedTech Funding Tracker - Science, vVARDIS, and more

GS MedTech Funding Tracker - Science, vVARDIS, and more

Latest Medtech News


More than $834M in disclosed funding and IPO proceeds marked a strong week for MedTech. Surgical robotics, brain-computer interfaces and pulsed electric field therapies attracted significant backing, alongside investment in advanced imaging, AI-powered diagnostics and technologies bringing more treatment options to patients. Read more below.

As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like these. Subscribe to our Industry Insights for weekly coverage.

Science raises $400M Series D to expand vision-restoring brain-computer interface

Science has raised $400M in Series D funding, with participation from Khosla Ventures, Tenet Healthcare, Y Combinator and others, bringing its total funding to over $900M. The investment will support the European rollout of PRIMA, preparation for its US launch and further development of its biohybrid neural interface technology.

Founder and CEO Max Hodak

vVARDIS prices IPO at $18 per share, set to list on NYSE

Swiss dental medtech company vVARDIS has priced its IPO at $18 per share, offering 9.72M Class A ordinary shares and raising approximately $175M. The shares are set to begin trading on the New York Stock Exchange under the ticker VVVV, marking the company's entry into the public markets.

Co-Founders Haley and Goly Abivardi

Galvanize Therapeutics raises $130M Series D to accelerate commercial growth and PEF innovation

Galvanize Therapeutics has raised an oversubscribed $130M Series D led by HealthQuest Capital, with participation from Olympus Innovation Ventures, Braidwell and existing investors. The funding will support Aliya’s commercial expansion, clinical evidence generation, advancement of RheOx for chronic bronchitis and development of next-generation pulsed electric field (PEF) technologies.

CEO Doug Godshall: "This investment positions us to accelerate our growth and pursue our broader vision of expanding the impact of PEF across oncology and chronic disease."

Remedy Robotics raises $62M Series B to advance robotic telesurgery

Remedy Robotics has raised $62M in Series B funding led by DCVC, with participation from the University of California, Skip Capital, Hostplus and existing investors. The funding will advance its N1 robotic telesurgical system toward pivotal clinical trials and FDA submission, enabling specialists to perform endovascular procedures remotely using robotic control and AI-powered imaging.

Co-Founders - CEO David Bell and CTO Jake Sganga

MedInTech raises KRW 33.8Bn $25.7M Series C to expand AI-powered surgical robotics

South Korean startup MedInTech has raised KRW 33.8Bn ($25.7M) in Series C funding co-led by Atinum Investment and KB Investment to expand its robotic endoscopy portfolio and advance therapeutic and surgical technologies. The funding will support R&D, regulatory approvals, manufacturing and international expansion of its AI-powered INTION S robotic endoscopy system.

CEO Chiwon Lee 

Intellizon raises nearly RMB 100M in Pre-A+ funding to advance implantable BCI

Intellizon has raised nearly RMB 100M ($15M) in a Pre-A+ round co-led by Puhua Capital and Furong Investment. The funding will advance clinical trials and production of its implantable bidirectional brain-computer interface platform, with applications including spinal cord injury, stroke and neurological disorders.

Exo secures $11.6M Gates Foundation grant to expand AI-powered ultrasound access

Exo has received an $11.6M grant from the Gates Foundation to advance its affordable handheld ultrasound platform, which combines silicon imaging with on-device AI. The funding will expand access to diagnostic imaging in low- and middle-income countries, supporting frontline healthcare workers with limited specialist resources.

CEO Sandeep Akkaraju: "This funding will help us advance a platform designed for communities where access to imaging and specialist expertise is limited. We’re grateful to the Gates Foundation for its continued support."

Current Surgical raises $9.5M Seed+ to advance automated cancer surgery

Current Surgical has closed an oversubscribed $9.5M Seed+ round led by SciFounders and True Ventures, alongside several other investors. The funding will advance its robotic, AI-powered focused ultrasound platform toward first-in-human studies for liver cancer, combining real-time imaging and tissue treatment within a needle-sized system designed for precision therapy.

Co-Founder and CEO Al Mashal

CoFlo Medical raises $6M seed to advance drug delivery platform

CoFlo Medical has raised $6M in seed funding backed by J2 Ventures to advance its drug delivery platform, designed to enable rapid, at-home administration of therapies for cancer and autoimmune diseases. Using a novel fluid dynamics technique, the technology aims to deliver high-dose, high-concentration biologics in seconds, potentially replacing lengthy hospital-based infusions with home treatment.

CEO and Co-Founder Simon Rufer: "At CoFlo, we’re on a mission to make treatments for diseases like cancer and autoimmune conditions more accessible."

AstraNu raises $3.5M seed to commercialize chip-scale OCT imaging technology

Nokia Bell Labs spinout AstraNu has raised $3.5M in seed funding led by Celesta Capital, with participation from the New Jersey Innovation Evergreen Fund. The funding will support validation and manufacturing of its compact, lower-cost OCT imaging engine for integration into medical devices, initially targeting ophthalmology.

President and General Manager Kevin Blalock: "Celesta's backing, together with the NJIEF's support, gives us the runway to get our engine into partner testbeds and validate the performance we have achieved."

EMVision secures $3M grant to expand portable brain scanner into trauma care

EMVision Medical Devices has been awarded a $3M Australian federal grant to develop and clinically test its First Responder portable brain scanner for traumatic brain injury. The project will assess its ability to detect bleeding following head injuries, expanding the device’s potential use beyond stroke assessment, with clinical studies expected to begin in 2027.

CEO and Co-Founder Scott Kirkland: "We are grateful for the support of the Department of Industry, Science and Resources in providing this non-delutive funding to generate the clinical evidence we need to advance our second indication."

IntelliProve raises €2.7M seed to expand camera-based health monitoring

Belgian company IntelliProve has raised €2.7M ($2.9M) in seed funding led by Miles Ahead, alongside The White and Yellow Cross and imec.istart. The funding will support clinical validation and regulatory progress for its software, which measures six health biomarkers through a 30-second face scan using standard cameras.

Co-Founders - Co-CEO Joeri Tulkens and CTO Tanguy Sanglet

Monitor Corporation secures $1.4M follow-on investment to expand medical AI

South Korean medical AI company Monitor Corporation has received a $1.4M follow-on investment from HB Investment, bringing its total backing to $2M. Its LuCAS-Plus lung cancer detection software is now used at around 170 sites in South Korea, while partnerships with GE HealthCare and overseas hospitals support international expansion.

CEO Kyong Joon Lee: 

Syntric Medical raises €500K pre-seed to improve lung biopsy accuracy

Eindhoven-based Syntric Medical has raised €500K ($548K) in pre-seed funding from BOM, imec.istart, Graduate Ventures and RoundOne to advance its robotic biopsy guidance technology. Using real-time CT imaging and respiratory motion tracking, its platform helps radiologists target small lung lesions more accurately, aiming to reduce inconclusive biopsies and repeat procedures.

CEO Joric Oude Vrielink: “With this investment, we are bringing our technology a step closer to the patient. This allows us to bring accurate, real-time guided interventions to the CT room, so that doctors can treat cancer with greater certainty and patients receive better outcomes,”

METANEURON raises tens of millions of yuan in Series A funding to expand sleep monitoring

METANEURON has secured tens of millions of yuan in Series A funding from Taiyi Investment. The funding will support hospital adoption and wider rollout of its full-lead dry-electrode polysomnography (PSG) system, alongside sleep-related diagnostic models and neuromodulation product development.

Founder Dong Yanbin

Go Back

We'd love to hear what you're building